TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds July 21, 1995
TCL Archive Arizona Cancer Center Convinces State To Set Lower Limits For Aflatoxin February 23, 1979
TCL Archive Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research August 3, 2012
